BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 23092578)

  • 41. Post-Translational Modifications of Transcription Factors Harnessing the Etiology and Pathophysiology in Colonic Diseases.
    Hsu CY; Fu SH; Chien MW; Liu YW; Chen SJ; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32369982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-Exome Sequencing Reveals
    Tang VT; Arscott P; Helms AS; Day SM
    Circ Genom Precis Med; 2018 Jan; 11(1):e001966. PubMed ID: 29874181
    [No Abstract]   [Full Text] [Related]  

  • 43. Building discontinuous liver sinusoidal vessels.
    Griffin CT; Gao S
    J Clin Invest; 2017 Mar; 127(3):790-792. PubMed ID: 28218626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant post-translational protein modifications in the pathogenesis of alcohol-induced liver injury.
    Osna NA; Carter WG; Ganesan M; Kirpich IA; McClain CJ; Petersen DR; Shearn CT; Tomasi ML; Kharbanda KK
    World J Gastroenterol; 2016 Jul; 22(27):6192-200. PubMed ID: 27468209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional role of post-translational modifications of Sp1 in tumorigenesis.
    Chang WC; Hung JJ
    J Biomed Sci; 2012 Nov; 19(1):94. PubMed ID: 23148884
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GATA4 in Regional Affairs.
    Verzi MP
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1505-1506. PubMed ID: 34310908
    [No Abstract]   [Full Text] [Related]  

  • 47. Post-translational modification: nature's escape from genetic imprisonment and the basis for dynamic information encoding.
    Prabakaran S; Lippens G; Steen H; Gunawardena J
    Wiley Interdiscip Rev Syst Biol Med; 2012; 4(6):565-83. PubMed ID: 22899623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Introduction: Posttranslational Protein Modification.
    Lin H; Caroll KS
    Chem Rev; 2018 Feb; 118(3):887-888. PubMed ID: 29439579
    [No Abstract]   [Full Text] [Related]  

  • 49. You Get a Modification, and You Get a Modification… Everyone Gets a Modification!
    Lunger JC; Batista PJ
    Mol Cell; 2020 Nov; 80(4):557-559. PubMed ID: 33217314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Corrigendum to 'Effects of PM
    Li R; Zhao Y; Shi J; Zhao C; Xie P; Huang W; Yong T; Cai Z
    Chemosphere; 2021 Jan; 262():128679. PubMed ID: 33182134
    [No Abstract]   [Full Text] [Related]  

  • 51. Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor.
    Yang F; Yao Y; Jiang Y; Lu L; Ma Y; Dai W
    J Biol Chem; 2016 Jan; 291(1):428. PubMed ID: 26724314
    [No Abstract]   [Full Text] [Related]  

  • 52. Cell signaling pathways for the regulation of GATA4 transcription factor: Implications for cell growth and apoptosis.
    Suzuki YJ
    Cell Signal; 2011 Jul; 23(7):1094-9. PubMed ID: 21376121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of Cardiac Transcription Factor GATA4 by Post-Translational Modification in Cardiomyocyte Hypertrophy and Heart Failure.
    Katanasaka Y; Suzuki H; Sunagawa Y; Hasegawa K; Morimoto T
    Int Heart J; 2016 Dec; 57(6):672-675. PubMed ID: 27818483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simple histone acetylation plays a complex role in the regulation of gene expression.
    Fukuda H; Sano N; Muto S; Horikoshi M
    Brief Funct Genomic Proteomic; 2006 Sep; 5(3):190-208. PubMed ID: 16980317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Post-transcriptional protein modification of Gata4].
    Yu LW; Gui YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):800-3. PubMed ID: 23092578
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of human GATA4 gene mutations on the activity of target gonadal promoters.
    Bouchard MF; Taniguchi H; Viger RS
    J Mol Endocrinol; 2009 Feb; 42(2):149-60. PubMed ID: 19008335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
    Yamamura N; Kishimoto T
    Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.